Fetal Cyclophosphamide Exposure Induces Testicular Cancer and Reduced Spermatogenesis and Ovarian Follicle Numbers in Mice
Open Access
- 1 April 2014
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (4) , e93311
Abstract
Exposure to radiation during fetal development induces testicular germ cell tumors (TGCT) and reduces spermatogenesis in mice. However, whether DNA damaging chemotherapeutic agents elicit these effects in mice remains unclear. Among such agents, cyclophosphamide (CP) is currently used to treat breast cancer in pregnant women, and the effects of fetal exposure to this drug manifested in the offspring must be better understood to offer such patients suitable counseling. The present study was designed to determine whether fetal exposure to CP induces testicular cancer and/or gonadal toxicity in 129 and in 129.MOLF congenic (L1) mice. Exposure to CP on embryonic days 10.5 and 11.5 dramatically increased TGCT incidence to 28% in offspring of 129 mice (control value, 2%) and to 80% in the male offspring of L1 (control value 33%). These increases are similar to those observed in both lines of mice by radiation. In utero exposure to CP also significantly reduced testis weights at 4 weeks of age to ∼70% of control and induced atrophic seminiferous tubules in ∼30% of the testes. When the in utero CP-exposed 129 mice reached adulthood, there were significant reductions in testicular and epididymal sperm counts to 62% and 70%, respectively, of controls. In female offspring, CP caused the loss of 77% of primordial follicles and increased follicle growth activation. The results indicate that i) DNA damage is a common mechanism leading to induction of testicular cancer, ii) increased induction of testis cancer by external agents is proportional to the spontaneous incidence due to inherent genetic susceptibility, and iii) children exposed to radiation or DNA damaging chemotherapeutic agents in utero may have increased risks of developing testis cancer and having reduced spermatogenic potential or diminished reproductive lifespan.Keywords
This publication has 45 references indexed in Scilit:
- Meta-analysis identifies four new loci associated with testicular germ cell tumorNature Genetics, 2013
- Effects of multiple doses of cyclophosphamide on mouse testes: Accessing the germ cells lost, and the functional damage of stem cellsReproductive Toxicology, 2011
- Epigenetic Reprogramming of Mouse Germ Cells toward TotipotencyCold Spring Harbor Symposia on Quantitative Biology, 2010
- The DM domain protein DMRT1 is a dose-sensitive regulator of fetal germ cell proliferation and pluripotencyProceedings of the National Academy of Sciences, 2009
- Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancerNature Genetics, 2009
- Polychlorinated Biphenyls and Risk of Testicular Germ Cell TumorsCancer Research, 2009
- Inferring biological mechanisms from spatial analysis: Prediction of a local inhibitor in the ovaryProceedings of the National Academy of Sciences, 2009
- Germ cell differentiation in the marmoset (Callithrix jacchus) during fetal and neonatal life closely parallels that in the humanHuman Reproduction, 2008
- Testicular germ cell tumor susceptibility genes from the consomic 129.MOLF-Chr19 mouse strainMammalian Genome, 2007
- IGF2/H19 imprinting analysis of human germ cell tumors (GCTs) using the methylation‐sensitive single‐nucleotide primer extension method reflects the origin of GCTs in different stages of primordial germ cell developmentGenes, Chromosomes and Cancer, 2005